Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 6
2015 1
2016 3
2017 4
2018 2
2019 4
2020 4
2021 8
2022 3
2023 4
2024 7
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment.
Rebecca VW, Xiao M, Kossenkov A, Godok T, Brown GS, Fingerman D, Alicea GM, Wei M, Ji H, Portuallo M, Bravo J, Elad V, Chen Y, Toska E, Fane ME, Couts KL, Villanueva J, Nathanson K, Arun KM, Warrier G, Yin X, Ding J, Liu Q, Goyal Y, Gopal YNV, Davies MA, Herlyn M. Rebecca VW, et al. Among authors: toska e. iScience. 2026 Jan 13;29(2):114669. doi: 10.1016/j.isci.2026.114669. eCollection 2026 Feb 20. iScience. 2026. PMID: 41704766 Free PMC article.
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.
Kittane S, Ladewig E, Li T, Love JR, Blawski R, Gao Y, Arruabarrena-Aristorena A, Zhao P, Dalrymple SL, Liu H, Guo X, Sallaku M, Kelkar N, Garcia-Martinez L, Carmona Sanz J, Chen W, Stoudmann C, Baldino L, Razavi-Mohseni M, Kalemi I, Beer MA, Castel P, Brennen WN, Scaltriti M, Morey L, Cocco E, Ji H, Chan HM, Battle A, Leslie CS, Karthaus WR, Toska E. Kittane S, et al. Among authors: toska e. Cancer Res. 2026 Mar 2;86(5):1113-1131. doi: 10.1158/0008-5472.CAN-25-2053. Cancer Res. 2026. PMID: 41379538 Free PMC article.
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.
Kumar R, Jonnatan S, Sanin DE, Vakkala V, Kadam A, Kumar S, Rosen DM, Dalrymple SL, Zhao L, Foley JR, Holbert CE, Nwafor A, Kittane S, Penner E, Apostolova P, Warner S, Dang CV, Toska E, Thompson EA, Isaacs JT, De Marzo AM, Brennen WN, Pearce EL, Stewart TM, Casero RA Jr, Denmeade SR, Sena LA. Kumar R, et al. Among authors: toska e. Cancer Res. 2026 Mar 2;86(5):1148-1165. doi: 10.1158/0008-5472.CAN-25-1532. Cancer Res. 2026. PMID: 41270152 Free PMC article.
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.
Cai Y, Zhao P, Wu F, Zhao H, Shao H, Marra A, Patel P, O'Connell E, Fink E, Miele MM, Li Z, De Stanchina E, Cocco E, Razavi P, Toska E, Fanning SW, Xu G, Sablina AA, Scaltriti M, Chandarlapaty S. Cai Y, et al. Among authors: toska e. Sci Transl Med. 2025 Jun 4;17(801):eadk7786. doi: 10.1126/scitranslmed.adk7786. Epub 2025 Jun 4. Sci Transl Med. 2025. PMID: 40465692 Free PMC article.
Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.
Murciano-Goroff YR, Foglizzo V, Chang J, Rekhtman N, Sisk AE, Gibson J, Judka L, Clemens K, Roa P, Ahmed SS, Bremer NV, Binaco CL, Muzungu SK, Rodriguez E, Merrill M, Sgroe E, Repetto M, Stadler ZK, Berger MF, Yu HA, Toska E, Kannan S, Verma CS, Drilon A, Cocco E. Murciano-Goroff YR, et al. Among authors: toska e. Clin Transl Med. 2025 May;15(5):e70338. doi: 10.1002/ctm2.70338. Clin Transl Med. 2025. PMID: 40437874 Free PMC article.
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer.
Kumar R, Jonnatan S, Sanin DE, Vakkala V, Kadam A, Kumar S, Dalrymple SL, Zhao L, Foley J, Holbert CE, Nwafor A, Kittane S, Penner E, Apostolova P, Warner S, Dang CV, Toska E, Thompson EA, Isaacs JT, De Marzo AM, Pearce EL, Stewart TM, Casero RA, Denmeade SR, Sena LA. Kumar R, et al. Among authors: toska e. medRxiv [Preprint]. 2024 Dec 13:2024.12.12.24318845. doi: 10.1101/2024.12.12.24318845. medRxiv. 2024. Update in: Cancer Res. 2026 Mar 2;86(5):1148-1165. doi: 10.1158/0008-5472.CAN-25-1532. PMID: 39711733 Free PMC article. Updated. Preprint.
Mutant ARID1A: igniting cancer immunotherapy.
Vokshi BH, Toska E. Vokshi BH, et al. Among authors: toska e. Trends Immunol. 2024 Aug;45(8):565-567. doi: 10.1016/j.it.2024.07.003. Epub 2024 Jul 26. Trends Immunol. 2024. PMID: 39068111 Review.
53 results